Study Design & Analytics

Advising on the design (including for adaptive studies), conduct, and statistical analysis of COVID-19 studies, including clinical trials.

Resources

Selected and recommended by the advisory group

Browse all resources selected by the coalition’s topic-specific groups

Webinar

Applicability of COVID-19 vaccine trial results to low-and middle-income countries

If you would like to submit a query to the Study Design & Analytics advisory group, please send us an email.

Submit a query

Advisory group current members

Advisory Group Member

I obtained my PhD in mathematical statistics in 1997. Since I wanted to continue my career in an applied field of research, I was very happy to start as senior statistician at the public health service of Amsterdam. There I specialised in the analysis of data that are collected in cohort studies, i.c. the Amsterdam Cohort Studies on HIV infection and AIDS (https://amsterdamcohortstudies.org). I performed and supervised many studies on infectious agents, especially those that are transmitted via sexual contact. Besides, I worked in several (medical) statistical research groups in the Netherlands, most notably in the academic medical center in Amsterdam. I joined OUCRU in January 2017 and became associate professor at Oxford University.

My research interests include: i) models for complex time-to-event data (competing risks, multi-state models), ii) models for complex longitudinal data, iii) prediction based on time-updated marker values, iv) causal inference, v) infectious diseases.

Coalition working group:
Study Design & Analytics
Advisory Group Member
Coalition working group:
Study Design & Analytics
Advisory Group Member
Coalition working group:
Study Design & Analytics
Advisory Group Member

Dr James Watson is a statistician and data analyst at MORU, Bangkok. His background is Mathematics and Computer Science (undergraduate) and Bayesian Statistics (DPhil). For the last 5 years he has worked as a postdoctoral researcher at MORU with a focus on clinical trial design for multiple tropical diseases, including malaria, snakebite envenoming, and Chagas disease.

Coalition working group:
Study Design & Analytics
Join CERCLE
We are looking for dedicated individuals and institutions who are eager to contribute their expertise and commitment to fast-track research in infectious diseases with potential for epidemics and pandemics, as well as antimicrobial resistance (AMR), specific to low-resource settings.